Cyclophosphamide Capsule
Product Images NDC 0054-0382

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 0054-0382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Struc (Image 01)

Chemical structure of cyclophosphamide hydrate showing a phosphoramide mustard moiety attached to a 6-membered ring with oxygen and nitrogen atoms, including a chlorine-substituted ethylene group and a water molecule (hydrate).*

FDA Label Image

Bl-25mg-label-100s.jpg (Image 02)

Cyclophosphamide 25 mg capsules label by Hikma Pharmaceuticals USA Inc. The label shows the drug's generic name, dosage form as capsules, strength of 25 mg, and a cytotoxic agent warning. Additional storage and handling instructions are included, along with the NDC number 0054-0382-25 and a 100-capsule count.*

FDA Label Image

Bl-50mg-0054-0383-25-100s.jpg (Image 03)

Label for Cyclophosphamide Capsules, USP 50 mg, a cytotoxic agent. The label indicates a package of 100 capsules, distributed by Hikma Pharmaceuticals USA Inc. Usage instructions emphasize swallowing capsules whole and wearing gloves when handling. Storage and dosage notes are included along the left side of the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.